1950-68-1

Basic information

• Product Name: 4-METHOXYBENZENESULFONYL HYDRAZIDE
• Synonyms: 4-METHOXYBENZENESULFONYL HYDRAZIDE;4-METHOXYBENZENESULPHONYL HYDRAZIDE;p-Anisolesulphonyl hydrazide;p-methoxybenzenesulphonyl hydrazide;4-METHOXYBENZENESULFONYL HYDRAZIDE, 97+%;4-Methoxybenzenesulfonyl hydrazide, 98+%;4-methoxybenzenesulfonohydrazide;p-Methoxybenzenesulfonohydrazide
• CAS NO: 1950-68-1
• Molecular Formula: C₇H₁₀N₂O₃S
• Molecular Weight: 202.23
• EINECS: 217-769-5
• Product Categories: Sulfonyl Hydrazides;Organic Building Blocks;Sulfur Compounds
• Mol File: 1950-68-1.mol
• Article Data: 76

Chemical Properties

• Melting Point: 111-114 °C(lit.)
• Boiling Point: 369.4 °C at 760 mmHg
• Flash Point: 177.2 °C
• Appearance: White Solid
• Density: 1.337 g/cm³
• Vapor Pressure: 1.19E-05mmHg at 25°C
• Refractive Index: 1.564
• Storage Temp.: under inert gas (nitrogen or Argon) at 2–8 °C
• PKA: 9.27±0.10(Predicted)
• BRN: 2694939
• CAS DataBase Reference: 4-METHOXYBENZENESULFONYL HYDRAZIDE(CAS DataBase Reference)
• NIST Chemistry Reference: 4-METHOXYBENZENESULFONYL HYDRAZIDE(1950-68-1)
• EPA Substance Registry System: 4-METHOXYBENZENESULFONYL HYDRAZIDE(1950-68-1)

Safety Data

• Hazard Codes: Xi
• Statements: 36/37/38
• Safety Statements: 26-36
• RIDADR: 3226
• WGK Germany: 3
• HazardClass: IRRITANT
• Hazardous Substances Data: 1950-68-1(Hazardous Substances Data)

Usage

General Description

4-Methoxybenzenesulfonyl hydrazide is a chemical compound primarily used in the industry as a blowing agent. Blowing agents are substances that help generate a gas to produce foam in polymer matrix. This particular compound is characterized by its ability to generate high gas yields and is noted for its excellent storage stability. It is used in various types of rubber and plastics. The chemical formula of 4-Methoxybenzenesulfonyl hydrazide is C7H10N2O3S. It should be handled with care as it can cause skin and eye irritation, as well as respiratory irritation upon inhalation. It is also harmful if swallowed.

InChI:InChI=1/C7H10N2O3S/c1-12-6-2-4-7(5-3-6)13(10,11)9-8/h2-5,9H,8H2,1H3

Upstream product

• 5857-42-1 4-methoxybenzenesulfonic acid 
• 100-66-3 methoxybenzene 
• 98-68-0 4-methoxy-phenyl-sulphonyl chloride 

Downstream Products

• 108488-99-9 4-methoxy-benzenesulfonic acid-(N'-ξ-D-glucopyranosyl-hydrazide) 
• 71124-86-2 4-methoxy-benzenesulfonic acid (1-ethyl-9,10-dihydro-6H,8H-2-thia-6-aza-cycloocta[cd]inden-7-ylidene)-hydrazide 
• 50491-75-3 4-methoxy-benzenesulfonic acid (2,3,4,5-tetrahydro-benzo[4,5]thieno[2,3-c]azepin-1-ylidene)-hydrazide 
• 18559-21-2 D-erythro-Pentulose-<4-methoxy-benzolsulfonylhydrazon> 
• 26164-74-9 4-methoxy-benzenesulfonic acid N'-(phenyl-thiocarbamoyl)-hydrazide 
• 111708-97-5 S-benzyl 4-methoxybenzenesulfonothioate 
• 114719-38-9 2C₂₁H₂₇N₅O₅S*C₄H₄O₄ 
• 100738-48-5 1,3-Bis-(p-methoxy-benzolsulfonhydrazono)-indanon-⁽²⁾ 
• 100738-49-6 2,3-Bis-(p-methoxy-benzolsulfonhydrazono)-indanon-⁽¹⁾ 
• 103937-03-7 1,2,3-Tris-(p-methoxy-benzolsulfonhydrazono)-indan 

Relevant articles and documents

DOCK1-INHIBITING COMPOUND AND USE THEREOF

Provided is a compound that is usable as an active ingredient of an anticancer agent. Preferably provided is a compound that has DOCK1-inhibiting activity and exerts an anticancer effect based on the activity. A compound represented by the following formula (A) or a salt thereof: wherein X represents a carbon atom or a nitrogen atom; Y represents an oxygen atom, a hydroxy group, or a hydrocarbon group; R1 and R2 are different, and each represents a hydrogen atom or a group represented by the following formula (A-1): (wherein R6 represents a pyrrolidino group or a phenyl group, and n2 is 0 or 1) ; R3 represents -CO-R7 (wherein R7 is an alkoxy group, an alkyl group, or an alkylamino group), a 1,3-oxazole group, an alkylhydroxy group, a hydrogen atom, or an oxygen atom; R4 represents a hydrogen atom, an oxygen atom, or a hydrocarbon group in which one or more hydrogen atoms may be replaced by one or more substituents; R5 represents a halogen atom, a halogenated alkyl group, or a halogenated alkylthio group; and n1 is an integer of 0 to 5; and

5-HT2A AGONISTS FOR USE IN TREATMENT OF DEPRESSION

The present invention relates to agonists of the 5-HT2A serotonin receptors and their medical uses. In one aspect the invention relates to 5-HT2A agonists of formula (I). In second aspect, the invention relates to selective 5-HT2A agonists of formula (II). In another aspect, the invention relates to mixed 5-HT2A/5-HT2C agonists of formula (III). In yet another aspect, the invention relates to 5-HT2A agonists for use in the treatment of a depressive disorder, more particular a 5-HT2A agonist for the use in the treatment of treatment-resistant depression.

Palladium-Catalyzed Direct C-H Arylation of 3-Butenoic Acid Derivatives

We report herein a direct method to synthesize 4-aryl-3-butenoic acid through a carboxylic-acid-directed oxidative Heck reaction. The various 4-aryl-3-butenoic acids are easily prepared in moderate to good yields. In view of the promising bioactivity of 4-phenyl-3-butenoic acid previously reported, its derivatives reported here may be bioactive.